Articles Blog Featured Pharmacy Research January 29, 20150CommentsEVOTAZ Approved By FDAToday the FDA approved Bristol-Myers Squibb Company’s new HIV antiretroviral combination EVOTAZ. Evotaz is a combination of atazanavir and Cobicistat and is approved for the treatment of HIV-1 infection in by Michelle
